XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.77

-3.3%

3:43 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (13993)	7/5/2000 4:42:53 PM
From: Robert K.	Read Replies (2) of 17367

Then perhaps we ALL (all) agree. In hindsight the p3 hemo trauma was not good. Of course hindsight is easy. Nobody saw that the placebo group would get bpi too. That study I post was out well after p3 trial underway. Thats why they has studies> trial and error. On another note natural bpi is not stable in vivo due to inactivation. I think half life is like 4 minutes. In either case, did you ever hear of a trial where the placebo group perhaps wasnt? Incredible if that the case. They might have been comparing lesser drug arm to greater drug arm? I cant wait till bax reveals their intentions. Standard K

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next